Cover |
Aug. 15, 2024 |
|---|---|
| Cover [Abstract] | |
| Document Type | 8-K/A |
| Amendment Flag | true |
| Amendment Description | ProPhase Labs, Inc. (the “Company”) is filing this Amendment No. 1 on Form 8-K/A (the “Amendment”) solely to include the disclosure of $16.1 million in working capital as of June 30, 2024 to the risk factor disclosed under Item 8.01 of its Current Report on Form 8-K as filed with the U.S. Securities and Exchange Commission (the “SEC”) on August 21, 2024 (the “Original Report”). Item 8.01 of the Original Report is amended and restated in its entirety as set out below. No other items or disclosures in the Original Report are being amended; however, this Amendment hereby restates and supersedes in its entirety the disclosures included in the Original Report. |
| Document Period End Date | Aug. 15, 2024 |
| Entity File Number | 000-21617 |
| Entity Registrant Name | PROPHASE LABS, INC. |
| Entity Central Index Key | 0000868278 |
| Entity Tax Identification Number | 23-2577138 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 711 Stewart Avenue |
| Entity Address, Address Line Two | Suite 200 |
| Entity Address, City or Town | Garden City |
| Entity Address, State or Province | NY |
| Entity Address, Postal Zip Code | 11530 |
| City Area Code | (215) |
| Local Phone Number | 345-0919 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, par value $0.0005 |
| Trading Symbol | PRPH |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | false |